PEPT Among Its Peers
End-of-day Nov 16, 2026 · 0 ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.6% | −1.7% | +8.4% | — | — | — | — | — | +9.2% |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$136 of every $1,000 in PEPT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 13.56% | $1,355.62 | 315 | $449K |
| 2 | ASNDAscendis Pharma A/S | Healthcare | 11.01% | $1,101.34 | 1,366 | $365K |
| 3 | NVONovo Nordisk A/S | Healthcare | 9.96% | $995.98 | 8,116 | $330K |
| 4 | PODDInsulet | Healthcare | 7.92% | $792.31 | 1,758 | $262K |
| 5 | PTGXProtagonist Therapeutics | Healthcare | 6.33% | $632.86 | 1,560 | $210K |
| 6 | SANSanofi | Financial Services | 5.92% | $592.26 | 2,015 | $196K |
| 7 | RYTMRhythm Pharmaceuticals | Healthcare | 5.59% | $559.17 | 1,686 | $185K |
| 8 | DARDarling Ingredients | Consumer Defensive | 4.09% | $409.29 | 2,449 | $136K |
| 9 | VKTXViking Therapeutics | Healthcare | 3.72% | $372.43 | 4,473 | $123K |
| 10 | —Bachem | — | 3.58% | $357.95 | 1,228 | $119K |
| 11 | —Ipsen | — | 3.00% | $300.16 | 538 | $99K |
| 12 | ZEALZealand Pharma A/S | — | 2.69% | $269.05 | 2,497 | $89K |
| 13 | PBLSParabilis Medicines | Healthcare | 2.56% | $256.30 | 3,066 | $85K |
| 14 | AUPHAurinia Pharmaceuticals | Healthcare | 2.29% | $228.63 | 4,672 | $76K |
| 15 | NEUNeuren Pharmaceuticals | Basic Materials | 2.10% | $210.42 | 4,326 | $70K |
PEPT has no close peers in our data yet: […]
Not enough history yet: PEPT needs a year of prices.
PEPT does not pay a distribution.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 13.56% |
| 2 | ASND | Ascendis Pharma A/S | 11.01% |
| 3 | NVO | Novo Nordisk A/S | 9.96% |
| 4 | PODD | Insulet | 7.92% |
| 5 | PTGX | Protagonist Therapeutics | 6.33% |
| 6 | SAN | Sanofi | 5.92% |
| 7 | RYTM | Rhythm Pharmaceuticals | 5.59% |
| 8 | DAR | Darling Ingredients | 4.09% |
| 9 | VKTX | Viking Therapeutics | 3.72% |
| 10 | ZEAL | Zealand Pharma A/S | 2.69% |